申请人:FORMA Therapeutics, Inc.
公开号:US10421732B2
公开(公告)日:2019-09-24
The present disclosure relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with an HDAC, e.g., HDAC6, having a Formula I:
where R, L, X1, X2, X3, X4, Y1, Y2, Y3, and Y4 are described herein.
本公开涉及锌依赖性组蛋白去乙酰化酶(HDAC)的抑制剂,可用于治疗与具有式I的HDAC(如HDAC6)相关的疾病或紊乱:
其中 R、L、X1、X2、X3、X4、Y1、Y2、Y3 和 Y4 在本文中描述。